Amantadine treatment for cocaine-dependent patients with severe withdrawal symptoms

References

• SAMHSA. Summary findings from the 2000 National Household Survey on Drug Abuse. Rockville, MD: Office of Applied Studies, Substance Abuse and Mental Health Services Administration, Report No.: DIII IS Publication No. (SMA) 01–3549 (2001).
   Google Scholar
• Alterman A, McKay, JR, Mulvaney, FD, McLellan, AT Prediction of Attrition from day hospital treatment in lower socioeconomic cocaine-dependent men. Drug and Alcohol Dependence 40, 227–233 (1996).
   PubMed Web of Science ®Google Scholar
• Carroll K, Rounsaville BJ, Gordon, LT et al Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Anil. Gen Psychiatry51, 177–187 (1994).
   PubMed Web of Science ®Google Scholar
• Kampman K, Rukstalis, M, Ehrman, R et al Open trials as a method of prioritizing medications for inclusion in controlled trials for cocaine dependence. Addictive Behaviors 24(2), 287–291 (1999).
   PubMedGoogle Scholar
• Kang S, Kleinman, PH, Woody, GH et al. Outcomes for cocaine abusers after once-a week psychosocial therapy. Am.Psychiatry 148, 630–635 (1991).
   PubMed Web of Science ®Google Scholar
• Means L, Small MA, Capone DM et al. Client demographics and outcome in out-patient cocaine treatment. Int. j Addicitions 24, 765–783 (1989).
   PubMed Web of Science ®Google Scholar
• Kampman KM, Volpicelli JR, McGinnis DE etal. Reliability and validity of the cocaine selective severity assessment. Addictive Behaviors 23(4), 49–461 (1998). Presents data supporting the reliability and validity of the CSSA as a measure of cocaine withdrawal symptom severity
   Google Scholar
• Kampman KM, Volpicelli JR, Mulvaney FD et al Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence. Addictive fkhaViOIN 27,251–260 (2002).
   PubMed Web of Science ®Google Scholar
• •Presents data from a study showing that the severity of cocaine withdrawal symptoms predicts treatment outcome in cocaine-dependent patients.
   Google Scholar
• Kampman KM, Alterman AT, Volpicelli JR et al Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in out-patient cocaine dependence treatment. Psychol. Addicitve Behaviors 15(1), 52–59 (2001).
   PubMed Web of Science ®Google Scholar
• •Presents data from a study showing that the severity of cocaine withdrawal symptoms predicts treatment outcome in cocaine-dependent patients.
   Google Scholar
• Mulvaney FD, Alterman AT, Boardman CR, Kampman K. Cocaine abstinence symptomatology and treatment attrition. j Substance Abuse Treatment 16 (2), 129–135 (1999).
   PubMedGoogle Scholar
• •Presents data from a study showing that the severity of cocaine withdrawal symptoms predicts treatment outcome in cocaine-dependent patients. iiKampman KM, Volpicelli JR, Alterman AT, Cornish JW, O'Brien CR Amantadine in the treatment of cocaine dependent patients with severe cocaine withdrawal symptoms. Ainj Psychiatry 157,2052-2054 (2000).
   Google Scholar
• ••Presents data suggesting that patients whoenter treatment with more severe cocaine withdrawal symptoms may respond better to treatment with arnantadine.
   Google Scholar
• Dackis C, Gold M. New concepts in cocaine addiciton: the dopamine depletion hypothesis. Neurosci. Biobehav Rev 9,469–477 (1985).
   PubMed Web of Science ®Google Scholar
• Davidson C, Ellinwood E, Lee T Altered sensitivity of dopamine autoreceptors in rat accumbens 1 and 7 days after intermittent or continuous cocaine withdrawal. BtMn Res. Bull. 51(1), 89–93 (2000).
   Google Scholar
• Weiss F, Markou A, Lorang M, Koob G. Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res. 593,314–318 (1992).
   PubMed Web of Science ®Google Scholar
• Mendelson JH, Teoh SK, Mello NK, Ellingboe J, Rhoades E. Acute effects of cocaine on plasma adrenocorticotropin hormone and prolactin levels in cocaine dependent men. J. Pharmacol Exp. Therapeutics263, 55–59 (1992).
   Google Scholar
• Sofuoglu M, Dudish-Poulsen S, Hatsukami D. Cocaine withdrawal symptoms are associated with enhanced subjective response to cocaine. Presented at the College on Problems of Drug Dependence Annual Meeting, Quebec City, Canada, 2002.
   Google Scholar
• Uslaner J, Kalechstein A, Richter T, Ling W, Newton T Association of depressive symptoms during abstinence with the subjective high produced by cocaine. Am. J. fiychMtry156(9), 1444–1446 (1999).
   Google Scholar
• Standaert D, Young A. Treatment of Central Nervous System Disorders. In: Goodman and Gilman 's The Pharmacological Basis of Therapeutics. 10th ed. Hardman J, Limbard L, Goodman Gilman A (Eds). McGraw Hill, New York, USA (2001).
   Google Scholar
• •Good overview of arnantadine pharmacology.
   Google Scholar
• Papeschi R. Amantadine may stimulate dopamine and noradrenaline receptors. Neuropharmacology13,77–83 (1973).
   Google Scholar
• Baldessarini R, Lipinski J, Chace K. Effects of amantadine hydrochloride on catecholamine metabolism in the brain of the rat. Biochem. Pharmacology 21,77–87 (1972).
   Google Scholar
• Herblin W Amantadine and catecholamine uptake. Biochem. Pharmacology 21,1993–1995 (1972).
   PubMedGoogle Scholar
• Von Voigtlander P, Moore K. Dopamine release from the brain in vivo by amantadine. Science 174,408–410 (1971).
   PubMedGoogle Scholar
• Mizoguchi K, Yokoo H, Yoshida M, Tanaka T, Tanaka M. Amantadine increases the extracelluar dopamine levels in the striatum by re-uptake inhibition and by N-methyl-d aspartate antagonism. Brain Res. 662(1-2), 255–258 (1994).
   PubMedGoogle Scholar
• Takahashi T, Yamashita H, Zhang Y, Nakamura S. Inhibatory efects of MK-801 on amantadine-induced dopamine release in rat striatum. Brain Res. Bull 141(6), 363–367 (1996).
   Google Scholar
• Stoof J, Booij J, Drukarch B, Wolters E. The antiParkinsonian drug amantadine inhibits the N-methyl-d-aspartatic acid evoked release of acetylcholine from rat neostriatum in a noncompetative way. Eur. J. Pharmacology 213,439–443 (1992).
   PubMed Web of Science ®Google Scholar
• Carlsson M, Carlsson A. Interactions between glutamatergic and monoaminergic systems in the basal ganglia - implications for schizophrenia and Parkinson's disease. Bends Neurosci. 13(7), 272–276 (1990).
   Google Scholar
• Klogether T, Turski L. Excitatory amino acids and the basal ganglia: implications for the treatment of Parkinson's disease. Trends Neumsci. 12(8), 285–286 (1989).
   Google Scholar
• Ritz M, Lamb R, Goldberg S, Kuhar M. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237, 1219–1223 (1987).
   PubMed Web of Science ®Google Scholar
• Koob G, Bloom E Cellular and molecular mechanisms of drug dependence. Science 242(4879), 715–723 (1988).
   PubMed Web of Science ®Google Scholar
• Kuhar M, Ritz M, Boja J. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14(7), 299–302 (1991).
   PubMed Web of Science ®Google Scholar
• Jentsch J, Taylor J. Impulsivity resulting form frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology 146,373–390 (1999).
   PubMed Web of Science ®Google Scholar
• •Good review of the pharmacology of cocaine.
   Google Scholar
• Robertson M, Leslie C, Bennett J. Apparent synaptic dopamine deficiency induced by withdrawal from chronic cocaine treatment. Brain Res. 538,337–339 (1991).
   Google Scholar
• Mendelson JH, Teoh SK, Lange U et al Anterior pituitary, adrenal and gonadal hormones during cocaine withdrawal. Am. I Bychiatry145(9), 1094–1098 (1988).
   PubMed Web of Science ®Google Scholar
• Wu J, Bell K, Najafi A et al Decreasing striatal 6-FDOPA uptake with increasing duration of cocaine withdrawal. Neumpsychopharmacology17 (6), 402–409 (1997).
   Google Scholar
• Little KY, Umesh N, Clark TB, Butts JD. Alteration of brain dopamine and serotonin levels in cocaine users. Am J. Psychiatry 153(9), 1216–1218 (1996).
   Google Scholar
• Malison RT, Best SE, van Dyke CH et al Elevated striatal dopamine transporters during acute cocaine abstinence as measured by 1231 Beta-CIT SPECT. Am. J. Psychiatry 155 (6), 832–834 (1998) .
   Google Scholar
• Little KY, Zhang L, Desmond T et al Striatal dopaminergic abnormalities in human cocaine users. A117. I Psychiatry 156, 238–245 (1999).
   Google Scholar
• McFarland K, Kalivas P The circuitry mediating cocaine induced reinstatement of drug seeking behavior. J Neuroscience 21, 8655–8663 (2001).
   PubMed Web of Science ®Google Scholar
• Hyytia P, Backstrom P, Liljequist S. Site- specific NMDA receptor antagonists produce differential effects on cocaine self-administration in rats. Eur. J Pharmacology 378,9–16 (1999).
   Google Scholar
• Ziedonis D, Kosten T Depression as a prognostic factor for pharmacological treatment of cocaine dependence. Ptychopharmacol Bull. 27(3), 337–334 (1991).
   Google Scholar
• MMWR. Prevention and control of influenza. Morbidity and Mortality Weekly Report35, 317–326 (1986).
   PubMedGoogle Scholar
• Kampman K, Volpicelli J, Alterman A et al Amantadine in the early treatment of cocaine dependence: a double-blind, placebo-controlled trial. Drug Alcohol Dependence 41,25–33 (1996).
   PubMed Web of Science ®Google Scholar
• •Presents data from a well-controlled clinical trial showing that among cocaine users in general, amantadine was not superior to placebo in promoting abstinence from cocaine.
   Google Scholar
• Alterman A, Droba M, Antelo R et al Amantadine may facilitate detoxification of cocaine addicts. Drug- Alcohol Dependence 31(1), 19–29 (1992).
   PubMedGoogle Scholar
• •• Presents data from a clinical trial showing amantadine to be superior to placebo in promoting abstinence from cocaine among cocaine-dependent patients.
   Google Scholar
• Handelsman L, Chordia P, Escovar I, Marion I, Lowinson J. Amantadine for the treatment of cociane dependence in methadone-maintained patients. Am. J Ptychiatry145(4), 533 (1988).
   Google Scholar
• Morgan C, Kosten T, Gawin F, Kleber H. A pilot trial of amantadine for ambulatory withdrawal for cocaine dependence. NIDA Res. Monograph 81, 81–83 (1987).
   Google Scholar
• Tennant F, Tarver A. Stepwise withdrawal from cocaine dependence; outcome of 106 consecutive cases. NIDA Res. Monograph 81,317 (1987).
   Google Scholar
• Tennant F, Sagherian A. Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence. Arch. Intern. Med. 147,109–112 (1987).
   PubMed Web of Science ®Google Scholar
• •Presents data from a clinical trial showing that amantadine was not superior to placebo for the treaiment of cocaine dependence.
   Google Scholar
• Kosten T, Morgan C, Falcione J, Schottenfeld R. Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine. Arch. Gen. Psychiatry 49, 894–898 (1992).
   PubMed Web of Science ®Google Scholar
• •Presents data from a clinical trial showing that amantadine was not superior to placebo for the treatment of cocaine dependence.
   Google Scholar
• Kolar A, Brown B, Weddington W, Haertzen C, Michaelson B, Jaffe J. Treatment of cocaine dependence in methadone-maintenance clients: a pilot study comparing the efficacy of desipramine and amantadine. int. J Addictions 27(7), 849–868 (1992).
   PubMed Web of Science ®Google Scholar
• •Presents data from a clinical trial showing that amantadine was not superior to placebo for the treatment of cocaine dependence.
   Google Scholar
• Weddington W, Brown B, Haertzen C et al Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence. Am. J Drug Akohol Abuse 17(2), 137–152 (1991).
   PubMed Web of Science ®Google Scholar
• •Presents data from a clinical trial showing that amantadine was not superior to placebo for the treatment of cocaine dependence.
   Google Scholar
• Giannini A, Folts D, Feather J, Sullivan B. Bromocriptine and amantadine in cocaine detoxification. Psychiatry Res. 29,11–16 (1989).
   PubMed Web of Science ®Google Scholar
• •Presents data from a clinical trial showing that amantadine was not superior to placebo for the treatment of cocaine dependence.
   Google Scholar
• Shoptaw S, Kintaudi P, Charuvastra C, Ling W A screening trial of amantadine as a medication for cocaine dependence. Drug-Alcohol Dependence 66,217–224 (2002).
   PubMed Web of Science ®Google Scholar
• ••Presents data from a trial showingamantadine to be superior to placebo in promoting abstinence from cocaine among cocaine-dependent patients.
   Google Scholar
• Halikas JA, Crosby RD, Nugent SM. The convergent validity of the Drug Impairment rating Scale for Cocaine. Ptychopharmacol Bull. 28(3), 315–318 (1992).
   PubMedGoogle Scholar
• Shoptaw S. Outcomes when using the GABA B agonist baclofen in human cocaine users. In: NIDA Research Monograph 180 Problems of Drug Dependence, 1999: Proceedings of the 61st Annual Scientific Meeting, The College on Problems of Drug Dependence. Louis S H, (Ed.) US Department of Health and Human Services, Bethesda, MD, USA (1999).
   Google Scholar
• Kampman KM, Volpicelli JR, Mulvaney FD et al Effectiveness of propranolol for cocaine dependence may depend on cocaine withdrawal symptom severity. Drug Alcohol Dependence 63(1), 69–78 (2001).
   PubMedGoogle Scholar
• •Cocaine withdrawal symptom severity may also predict response to treatment with the beta blocker propranolol among cocaine-dependent patients.
   Google Scholar